FDA rejects drug touted as possible COVID-19 ‘cure’ by MyPillow CEO

The FDA on Friday gave its safety thumbs down to Oleandrin — the extract the MyPillow CEO has pushed as a possible coronavirus cure. Oleandrin, could not “reasonably be expected to be safe” as a dietary supplement, the Food & Drug Administration wrote in a letter to Phoenix Biotechnology, which had applied for the agency’s…

https://nypost.com/2020/09/05/fda-rejects-drug-touted-as-possible-covid-19-cure-by-mypillow-ceo/